Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improvement in Guideline-Directed Medical Therapy After Tricuspid Transcatheter Edge-to-Edge Repair in Participants With Reduced Left Ventricular Function

NCT07578129 is registered in ClinicalTrials.gov with Ceric Sàrl as lead sponsor.

NCT NCT07578129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07578129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improvement in Guideline-Directed Medical Therapy After Tricuspid Transcatheter Edge-to-Edge Repair in Participants With Reduced Left Ventricular Function
Lead sponsor
Ceric Sàrl
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 31, 2027
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular (lv) systolic dysfunction, left ventricular cardiac dysfunction, left ventricular dysfunction, left ventricular ejection fraction, tricuspid insufficiency, tricuspid regurgitation (tr)